Other Viruses Citation List: March 30 - April 12, 2012

Hepatitis B virus

1. Synthesis, Structure-Activity Relationships and Biological Evaluation of Caudatin Derivatives as Novel Anti-hepatitis B Virus Agents. Wang, L.J., C.A. Geng, Y.B. Ma, X.Y. Huang, J. Luo, H. Chen, R.H. Guo, X.M. Zhang, and J.J. Chen, Bioorganic & Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[22472044].
[PubMed]. OV_0330-041212.

Hepatitis C Virus

2. 25-Hydroxyvitamin D(3) Suppresses Hepatitis C Virus Production. Matsumura, T., T. Kato, N. Sugiyama, M. Tasaka-Fujita, A. Murayama, T. Masaki, T. Wakita, and M. Imawari, Hepatology (Baltimore, Md.), 2012. [Epub ahead of print]; PMID[22487892].
[PubMed]. OV_0330-041212.

3. Structure-based Macrocyclization Yields Hepatitis C Virus NS5B Inhibitors with Improved Binding Affinities and Pharmacokinetic Properties. Cummings, M.D., T.I. Lin, L. Hu, A. Tahri, D. McGowan, K. Amssoms, S. Last, B. Devogelaere, M.C. Rouan, L. Vijgen, J.M. Berke, P. Dehertogh, E. Fransen, E. Cleiren, L. van der Helm, G. Fanning, K. Van Emelen, O. Nyanguile, K. Simmen, P. Raboisson, and S. Vendeville, Angewandte Chemie (International ed. in English), 2012. [Epub ahead of print]; PMID[22473861].
[PubMed]. OV_0330-041212.

4. 5-Benzothiazole Substituted Pyrimidine Derivatives as HCV Replication (Replicase) Inhibitors. Arasappan, A., F. Bennett, V. Girijavallabhan, Y. Huang, R. Huelgas, C. Alvarez, L. Chen, S. Gavalas, S.H. Kim, A. Kosinski, P. Pinto, R. Rizvi, R. Rossman, B. Shankar, L. Tong, F. Velazquez, S. Venkatraman, V.A. Verma, J. Kozlowski, N.Y. Shih, J.J. Piwinski, M. Maccoss, C.D. Kwong, J.L. Clark, A.T. Fowler, F. Geng, H.S. Kezar, 3rd, A. Roychowdhury, R.C. Reynolds, J.A. Maddry, S. Ananthan, J.A. Secrist, 3rd, C. Li, R. Chase, S. Curry, H.C. Huang, X. Tong, and F.G. Njoroge, Bioorganic & Medicinal Chemistry Letters, 2012. [Epub ahead of print]; PMID[22472692].
[PubMed]. OV_0330-041212.

5. Discovery of 4'-Azido-2'-deoxy-2'-C-methyl cytidine and Prodrugs thereof: A Potent Inhibitor of Hepatitis C Virus Replication. Nilsson, M., G. Kalayanov, A. Winqvist, P. Pinho, C. Sund, X.X. Zhou, H. Wahling, A.K. Belfrage, M. Pelcman, T. Agback, K. Benckestock, K. Wikstrom, M. Boothee, A. Lindqvist, C. Rydegard, T.H. Jonckers, K. Vandyck, P. Raboisson, T.I. Lin, S. Lachau-Durand, H. de Kock, D.B. Smith, J.A. Martin, K. Klumpp, K. Simmen, L. Vrang, Y. Terelius, B. Samuelsson, S. Rosenquist, and N.G. Johansson, Bioorganic & Medicinal Chemistry Letters, 2012. [Epub ahead of print]; PMID[22472694].
[PubMed]. OV_0330-041212.

6. Discovery of Novel Urea-based Hepatitis C Protease Inhibitors with High Potency against Protease-inhibitor-resistant Mutants. Kazmierski, W.M., R. Hamatake, M. Duan, L.L. Wright, G.K. Smith, R.L. Jarvest, J.J. Ji, J.P. Cooper, M.D. Tallant, R.M. Crosby, K. Creech, A. Wang, X. Li, S. Zhang, Y.K. Zhang, Y. Liu, C.Z. Ding, Y. Zhou, J.J. Plattner, S.J. Baker, W. Bu, and L. Liu, Journal of Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[22471376].
[PubMed]. OV_0330-041212.

7. A Plant-derived Flavonoid Inhibits Entry of All HCV Genotypes into Human Hepatocytes. Haid, S., A. Novodomska, J. Gentzsch, C. Grethe, S. Geuenich, D. Bankwitz, P. Chhatwal, B. Jannack, T. Hennebelle, F. Bailleul, O.T. Keppler, M. Ponisch, R. Bartenschlager, C. Hernandez, M. Lemasson, A. Rosenberg, F. Wong-Staal, E. Davioud-Charvet, and T. Pietschmann, Gastroenterology, 2012. [Epub ahead of print]; PMID[22465429].
[PubMed]. OV_0330-041212.

8. Antiviral Activity of Inonotus obliquus Fungus Extract towards Infection Caused by Hepatitis C Virus in Cell Cultures. Shibnev, V.A., D.V. Mishin, T.M. Garaev, N.P. Finogenova, A.G. Botikov, and P.G. Deryabin, Bulletin of Experimental Biology and Medicine, 2011. 151(5): p. 612-4; PMID[22462058].
[PubMed]. OV_0330-041212.

9. Synthesis of the HCV Protease Inhibitor Vaniprevir (MK-7009) Using Ring-closing Metathesis Strategy. Kong, J., C.Y. Chen, J. Balsells-Padros, Y. Cao, R.F. Dunn, S.J. Dolman, J. Janey, H. Li, and M.J. Zacuto, The Journal of Organic Chemistry, 2012. [Epub ahead of print]; PMID[22458448].
[PubMed]. OV_0330-041212.

10. A New Class of Synthetic Peptide Inhibitors Block Attachment and Entry of Human Pathogenic Viruses. Krepstakies, M., J. Lucifora, C.H. Nagel, M.B. Zeisel, B. Holstermann, H. Hohenberg, I. Kowalski, T. Gutsmann, T.F. Baumert, K. Brandenburg, J. Hauber, and U. Protzer, The Journal of Infectious Diseases, 2012. [Epub ahead of print]; PMID[22457281].
[PubMed]. OV_0330-041212.

HSV-1

11. Efficacy of Bidens pilosa Extract against Herpes Simplex Virus Infection in Vitro and in Vivo. Nakama, S., K. Tamaki, C. Ishikawa, M. Tadano, and N. Mori, Evidence-Based Complementary and Alternative Medicine : eCAM, 2012. 2012: p. 413453; PMID[22474501].
[PubMed]. OV_0330-041212.

HSV-2

12. A 3-O Sulfated Heparan Sulfate Binding Peptide Preferentially Targets Herpes Simplex Virus Type-2 Infected Cells. Ali, M.M., G.A. Karasneh, M.J. Jarding, V. Tiwari, and D. Shukla, Journal of Virology, 2012. [Epub ahead of print]; PMID[22491462].
[PubMed]. OV_0330-041212.

Citations from the ISI Web of Knowledge Listings for O.V.

13. A Novel Class of Highly Potent Irreversible Hepatitis C Virus NS5B Polymerase Inhibitors. Chen, K.X., C.A. Lesburg, B. Vibulbhan, W.Y. Yang, T.Y. Chan, S. Venkatraman, F. Velazquez, Q.B. Zeng, F. Bennett, G.N. Anilkumar, J. Duca, Y.H. Jiang, P. Pinto, L. Wang, Y.H. Huang, O. Selyutin, S. Gavalas, H.Y. Pu, S. Agrawal, B. Feld, H.C. Huang, C. Li, K.C. Cheng, N.Y. Shih, J.A. Kozlowski, S.B. Rosenblum, and F.G. Njoroge, Journal of Medicinal Chemistry, 2012. 55(5): p. 2089-2101; ISI[000301170000026].
[WOS]. OV_0330-041212.

14. Conformationally Locked Nucleoside Analogues Based on the Bridgehead Substituted 7-Oxonorbornane and Their Antiviral Properties. Dejmek, M., H. Hrebabecky, M. Dracinsky, J. Neyts, P. Leyssen, H. Mertlikova-Kaiserova, and R. Nencka, Collection of Czechoslovak Chemical Communications, 2011. 76(12): p. 1549-1566; ISI[000299816100009].
[WOS]. OV_0330-041212.

15. Integrated Structure-based Activity Prediction Model of Benzothiadiazines on Various Genotypes of HCV NS5b Polymerase (1a, 1b and 4) and Its Application in the Discovery of New Derivatives. Ismail, M.A.H., D.A.A. El Ella, K.A.M. Abouzid, and A.H. Mahmoud, Bioorganic and Medicinal Chemistry, 2012. 20(7): p. 2455-2478; ISI[000301379300029].
[WOS]. OV_0330-041212.

16. 7-Halogenated 7-Deazapurine 2 '-C-Methylribonucleosides. Seela, F., S. Budow, K.Y. Xu, X.H. Peng, and H. Eickmeier, Collection of Czechoslovak Chemical Communications, 2011. 76(12): p. 1413-1431; ISI[000299816100002].
[WOS]. OV_0330-041212.